MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life sciences, introduces the CellKey™384 System. The new platform brings the simplified workflow, biorelevance and rich information of a label-free cell-based impedance assay to high throughput screening. Visit us at booth #18 and at www.cellkey.com to learn more.

GE Healthcare provides innovative enabling tools to facilitate drug discovery, spanning target identification through primary and secondary screening to lead profiling. BiacoreT systems, the gold standard for label-free interaction analysis, generate comprehensive data on molecular interactions, giving insights into biological functions and disease mechanisms, and facilitating efficient therapeutic development.

Using our unique expertise in optics, materials science, surfaces, and biology, we provide a full range of novel solutions that improve productivity and enable breakthrough discoveries.  Our latest innovation, the Corning® Epic® System, combines advanced optics and chemistry to enable the high-throughput, label-free study of both biochemical and cellular interactions.

BioTrove RapidFire™ Lead Discovery provides label-free, microliter-scale assay development and screening of intractable targets for drug discovery research. Mass spectrometry-based high throughput screening of drug targets and Cyp inhibition assays average five seconds per sample. Targets include: triglycerides, lipids, fatty acids, prostaglandins, steroids, co-enzyme A derivatives, neurotransmitters, antifungals and antiinfectives.